Phase 2 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been newly diagnosed with a specific type of acute myeloid leukemia (AML) involving a genetic change called CBFβ::MYH11 (confirm with trial site)
- Your general health and ability to carry out daily activities falls within an acceptable range, as measured by a standard medical scale (ECOG score 0–3) (confirm with trial site)
- You are willing and able to sign a consent form before any study-related steps begin
This trial also includes people who may not be suitable for intensive chemotherapy. You may fall into this "unfit" category if at least one of the following applies to you:
- You are older than 75 years
- You have serious problems with your heart, lungs, kidneys, or liver
- You have an active infection that is not responding to treatment
- You have cognitive impairment (such as problems with memory or thinking)
- You have other health conditions that your doctor feels make intensive chemotherapy unsuitable for you
Who may not be able to join:
- You have already received certain types of treatment for AML, such as chemotherapy or targeted drug therapy (some exceptions may apply — confirm with trial site)
- You are currently pregnant or breastfeeding
- You are not able to attend all required study visits or follow all study procedures, including follow-up appointments
- Your doctor determines there are other reasons that make this study unsuitable for you
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ying Wang, The First Affiliated Hospital of Soochow University
Phone: 008613656214782
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
composite complete remission rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.